Compliance into the Weeds: Of Wal-Mart, Tariffs and Stakeholder Capitalism
FCPA Compliance Report-Bonus Episode, the Walmart FCPA Enforcement Action
This Week in FCPA-Episode 159, week ending June 21, 2019 – the KPMG Trainwreck and Walmart Settles
This Week in FCPA-Episode 80, The Last Jedi Edition
This Week in FCPA-Episode 77, the Home for the Holidays Edition
Day 20: What Does Innovation in Compliance Look Like?
This Week in FCPA-Episode 56
This Week in FCPA-Episode 1
Fcpa Compliance and Ethics Report-Episode 58-Interview with Michael Scher
FCPA Compliance and Ethics Report-Episode 30-Interview with the FCPA Professor-Part 2
FCPA Compliance and Ethics Report-Episode 18-Walmart-Be a Leader in Compliance
The award-winning Compliance into the Weeds is the only weekly podcast that takes a deep dive into a compliance-related topic, literally going into the weeds to explore a subject more fully. Are you looking for some...more
Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene” by addressing “regulatory concerns over their union”....more
HSBC chief John Flint is out just 18 months after he assumed the role as head of the London-based bank, likely due to clashes with Board Chair Mark Tucker and the lender’s focus on expanding in China. HSBC also announced it...more
Treasury Secretary Steven Mnuchin is the latest prominent government official to express concerns about Facebook’s coming Libra launch. Speaking at a briefing yesterday, Mnuchin focused on national security issues related to...more